Form 4: BioMarin Pharmaceutical Director Jean-Jacques Bienaime Sells Shares
SEC Form 4
Director Jean-Jacques Bienaime of BioMarin Pharmaceutical Inc. reports selling 2,000 shares of common stock in early March 2024.
Summary
- On March 5th and 6th, 2024, Jean-Jacques Bienaime, a director at BioMarin Pharmaceutical Inc., sold a total of 2,000 shares of common stock.
- The sales were executed in two transactions: 1,000 shares on March 5th at $85.51 per share and 1,000 shares on March 6th at $86.713 per share.
- Following these transactions, Bienaime directly owns 560,203 shares of BioMarin common stock.
- Bienaime also indirectly owns 247,333 shares through the Jean-Jacques Bienaime Family Trust, 100 shares as UTMA custodian for child 1, and 100 shares as UTMA custodian for child 2.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of stock sales by a company director. The impact on investor sentiment is likely to be minimal unless the sales are unusually large or frequent.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company executives and directors.
Key Dates
| Date | Description |
|---|---|
| 03/05/2024 | Sale of 1,000 shares of common stock at $85.51 per share. |
| 03/06/2024 | Sale of 1,000 shares of common stock at $86.713 per share. |
| 03/07/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.